Seki Hiroyuki
Center for Maternal, Fetal and Neonatal Medicine, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Acta Obstet Gynecol Scand. 2014 Oct;93(10):959-64. doi: 10.1111/aogs.12473. Epub 2014 Sep 17.
The "two-stage disorder" theory that is assumed for the etiology of preeclampsia hypothesizes that antiangiogenic and angiogenic factors and/or placental debris play an important role in this disorder. The physiological actions of placental debris occur via the balance between antiangiogenic and angiogenic factors. Accordingly, this balance between antiangiogenic and angiogenic factors should be investigated to elucidate the various pathological features of preeclampsia. Their accurate evaluation is needed to investigate not only antiangiogenic factors (such as sFlt-1 and sEng) and angiogenic factors (such as vascular endothelial growth factor, placental growth factor and transforming growth factor-β) but also the expression level of their receptors such as Flt-1 and Eng. However, it is ethically and technically difficult to investigate the above-mentioned factors at antepartum in human patients. The examination of the ratios of sFlt-1/vascular endothelial growth factor receptor ligands and sEng/transforming vascular endothelial growth factor-β and the use of experimental animal models may help in elucidating various unresolved issues in preeclampsia.
子痫前期病因所假定的“两阶段紊乱”理论推测,抗血管生成和血管生成因子及/或胎盘碎片在该病症中起重要作用。胎盘碎片的生理作用通过抗血管生成和血管生成因子之间的平衡发生。因此,应研究抗血管生成和血管生成因子之间的这种平衡,以阐明子痫前期的各种病理特征。不仅需要准确评估抗血管生成因子(如可溶性血管内皮生长因子受体-1和可溶性内皮因子)和血管生成因子(如血管内皮生长因子、胎盘生长因子和转化生长因子-β),还需要评估它们的受体(如Flt-1和Eng)的表达水平。然而,在人类患者产前研究上述因素在伦理和技术上都很困难。检测可溶性血管内皮生长因子受体-1/血管内皮生长因子受体配体和可溶性内皮因子/转化血管内皮生长因子-β的比值以及使用实验动物模型可能有助于阐明子痫前期中各种未解决的问题。